Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time.
Sebastian HavervallUlrika MarkingNina Greilert-NorinMax GordonHenry NgWanda ChristMia PhillipsonPeter NilssonSophia HoberKim BlomJonas KlingströmSara MangsboMikael ÅbergCharlotte ThålinPublished in: Clinical & translational immunology (2022)
These findings imply that prior SARS-CoV-2 infection should be taken into consideration when planning booster doses and design of current and future COVID-19 vaccine programmes.